Guard Therapeutics International AB
Research Guard Therapeutics International AB (GUARD) on Bullrun: market cap SEK 34.28M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGUARD
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryBiotechnology
- CurrencySEK
- Market capSEK 34.28M
- Financial periodQ4 2025
- Net income-SEK 16.33M
- Free cash flow-SEK 18.65M
Valuation Snapshot
latest market cap is SEK 34.28M.
About Guard Therapeutics International AB
Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, develops novel therapies for diseases with high unmet medical need, primarily focusing on various forms of kidney disease in Sweden. The company's pipeline products include RMC-035, an intact therapeutic A1M protein, that is in a Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in a preclinical trial to treat sepsis.
Frequently asked questions
What is Guard Therapeutics International AB's market cap?
Guard Therapeutics International AB's market capitalization is SEK 34.28M.
What does Guard Therapeutics International AB do?
Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, develops novel therapies for diseases with high unmet medical need, primarily focusing on various forms of kidney disease in Sweden.